Attention deficit hyperactivity disorder and Bone density decreased

Summary:

Bone density decreased is found among people with Attention deficit hyperactivity disorder, especially for people who are female, 10-19 old.

The study analyzes which people have Bone density decreased with Attention deficit hyperactivity disorder. It is created by eHealthMe based on reports of 32 people who have Attention deficit hyperactivity disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Attention deficit hyperactivity disorder?

Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 609 drugs and 1,394 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.

What is Bone density decreased?

Bone density decreased is found to be associated with 1,125 drugs and 946 conditions by eHealthMe. Check the latest studies of Bone density decreased.

On Jul, 26, 2026

32 people who have Attention Deficit Hyperactivity Disorder and Bone Density Decreased are studied.

Would you have Bone density decreased when you have Attention deficit hyperactivity disorder?

Gender of people who have Attention Deficit Hyperactivity Disorder and experienced Bone Density Decreased *:

female: 53.33 %
male: 46.67 %

Age of people who have Attention Deficit Hyperactivity Disorder and experienced Bone Density Decreased *:

Common co-existing conditions for these people *:

Depression: 10 people, 31.25%
Pain: 6 people, 18.75%
Hiv Infection: 6 people, 18.75%
Inflammation: 5 people, 15.62%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 15.62%
High Blood Pressure: 5 people, 15.62%
Bacterial Infection: 5 people, 15.62%
Fungal Infection: 5 people, 15.62%
Stress And Anxiety: 5 people, 15.62%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 5 people, 15.62%

Common drugs taken by these people *:

Vyvanse: 7 people, 21.88%
Heparin: 5 people, 15.62%
Hydrocodone Bitartrate And Acetaminophen: 5 people, 15.62%
Hydroxyzine: 5 people, 15.62%
Oxycodone: 5 people, 15.62%
Atripla: 4 people, 12.50%
Risperdal: 4 people, 12.50%
Ritalin: 4 people, 12.50%
Fosamax: 4 people, 12.50%
Opana: 3 people, 9.38%

Common symptoms for these people *:

Stress And Anxiety: 12 people, 37.50%
Pain: 10 people, 31.25%
Depression: 9 people, 28.12%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 7 people, 21.88%
Back Pain: 7 people, 21.88%
Emotional Distress: 7 people, 21.88%
Headache (pain in head): 6 people, 18.75%
Drug Ineffective: 6 people, 18.75%
Osteoporosis (bones weak and more likely to break): 5 people, 15.62%
Weight Increased: 5 people, 15.62%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Bone density decreased?

- Check whether Bone density decreased is associated with a drug or a condition

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Bone density decreased and Attention deficit hyperactivity disorder, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.